tiprankstipranks
GT Biopharma (GTBP)
NASDAQ:GTBP
US Market

GT Biopharma (GTBP) Financial Statements

Compare
230 Followers

GT Biopharma Financial Overview

GT Biopharma's market cap is currently $6.29M. The company's EPS TTM is $-7.024; its P/E ratio is ―; GT Biopharma is scheduled to report earnings on May 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -14.36M$ -13.58M$ -21.26M$ -57.52M$ -6.76M
EBITDA$ -14.36M$ 5.98M$ 0.00$ 0.00$ -24.98M
Net Income$ -13.16M$ -7.60M$ -20.50M$ -58.69M$ -31.62M
Balance Sheet
Cash & Short-Term Investments$ 3.95M$ 13.97M$ 16.51M$ 31.98M$ 5.30M
Total Assets$ 4.23M$ 14.11M$ 16.74M$ 32.17M$ 5.66M
Total Debt$ 0.00$ 58.00K$ 174.00K$ 31.00K$ 26.33M
Net Debt$ -3.95M$ -1.02M$ -5.50M$ -8.94M$ 21.04M
Total Liabilities$ 5.90M$ 6.63M$ 5.00M$ 10.26M$ 35.09M
Stockholders' Equity$ -1.67M$ 7.48M$ 11.73M$ 21.91M$ -29.26M
Cash Flow
Free Cash Flow$ -12.90M$ -8.85M$ -15.22M$ -15.61M$ -7.26M
Operating Cash Flow$ -12.90M$ -8.85M$ -15.22M$ -15.61M$ -7.26M
Investing Cash Flow$ 12.89M$ -2.01M$ 12.14M$ -23.04M$ 0.00
Financing Cash Flow$ 2.98M$ 6.27M$ -224.00K$ 42.32M$ 12.53M
Currency in USD

GT Biopharma Earnings and Revenue History

GT Biopharma Debt to Assets

GT Biopharma Cash Flow

GT Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis